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University Medical School, New Orleans, LouisianaABSTRACT Using a high throughput screen, we have identified a family of 12-residue long peptides that spontaneously trans-
locate across membranes. These peptides function by a poorly understood mechanism that is very different from that of the well-
known, highly cationic cell penetrating peptides such as the tat peptide from HIV. The newly discovered translocating peptides
can carry polar cargoes across synthetic bilayers and across cellular membranes quickly and spontaneously without disrupting
the membrane. Here we report on the biophysical characterization of a representative translocating peptide from the selected
family, TP2, as well as a negative control peptide, ONEG, from the same library. Wemeasured the binding of the two peptides to
lipid bilayers, their secondary structure propensities, their dispositions in bilayers by neutron diffraction, and the response of the
bilayer to the peptides. Compared to the negative control, TP2 has a greater propensity for membrane partitioning, although it
still binds only weakly, and a higher propensity for secondary structure. Perhaps most revealing, TP2 has the ability to penetrate
deep into the bilayer without causing significant bilayer perturbations, a property that may help explain its ability to translocate
without bilayer permeabilization.INTRODUCTIONThe permeability barrier imposed by the lipid bilayer mem-
brane is one of the essential requirements for life. However,
this barrier also prevents the cellular entry of polar com-
pounds that could be beneficial in the laboratory or in the
clinic. There are many classes of potentially useful, but
not membrane-permeable, compounds including drug-like
small molecules, metabolite analogs, peptides, proteins, im-
aging agents, small RNAs, DNA, and nanoparticles, but
currently there are few, if any, efficient nonperturbing
methods of delivering such compounds into cells. Some of
the existing methods that are used for this purpose are based
on the physical disruption of the membrane. These include
electroporation (1), detergent-like disruption (e.g., lipidic
transfection reagents) (2), lipid vesicle fusion (3), use of
pore-forming peptides (4), and use of membrane-permeabi-
lizing proteins (5). These methods all have significant draw-
backs, including low efficiency, toxicity, and disruption of
cell physiology. Furthermore, few of these methods, if
any, can be used in vivo. The other major category of tech-
niques for delivery of polar compounds into cells are those
that take advantage of existing cellular pathways. If properly
targeted to a cellular pathway, polar compounds can enter
cells via endocytosis, pinocytosis, or phagocytosis (6,7).
These approaches can theoretically be used in vivo; how-
ever, they also have low efficiency, mainly because of inef-
ficient release from the endosomal pathways (6).Submitted December 13, 2012, and accepted for publication April 22, 2013.
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0006-3495/13/06/2419/10 $2.00A polypeptide sequence that can translocate spontane-
ously across membranes with an attached polar cargo would
have advantages over the methods that are available to
deliver polar compounds into living cells. For this reason,
we have, to our knowledge, taken a new approach to
discover novel spontaneous membrane-translocating pep-
tides using combinatorial peptide libraries and orthogonal
high throughput screens (8). By using an orthogonal screen
that simultaneously assays for peptide-induced membrane
permeabilization and for spontaneous peptide translocation
across bilayers, we identified a family of translocating pep-
tides from a rational 10,384-member peptide library (8).
These 12-residue peptides, which have a conserved LRLLR
sequence motif, cross synthetic lipid bilayers and cellular
membranes quickly (rate > 0.1 s1), even when attached
to non-membrane-permeable cargoes. Translocation into
cells is spontaneous and is independent of cellular energy-
dependent processes such as endocytosis, allowing delivery
of polar cargoes directly to the cytoplasm without toxicity
(8). Thus, the spontaneous membrane-translocating peptides
are very different from the highly cationic cell-penetrating
peptides such as the tat peptide from the HIV Tat protein,
which enters cells via endocytosis and is localized predom-
inantly in endocytic compartments, and not the cytoplasm
(6,8). Because of this, the cargo delivery capabilities of
the two peptide classes are also different, with the cell-pene-
trating peptides being able to carry much larger cargo, but
mainly to endocytic compartments. On the other hand, the
spontaneously translocating peptides can deliver cargo up
to 1000 Da directly across the plasma membrane (unpub-
lished results).http://dx.doi.org/10.1016/j.bpj.2013.04.043
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capabilities of the identified peptides are now well estab-
lished (8), the details of their interactions with lipid mem-
branes and the mechanism of translocation are not known.
This is a roadblock to their optimization and widespread
utilization. Here we report on the first biophysical character-
ization of these peptides in membranes, to our knowledge.
We investigate one membrane-translocating peptide, TP2,
as well as an observed nontranslocating peptide from the
same peptide library, ONEG, that is used here as a negative
control. We measure the binding of the two peptides to bi-
layers, their secondary structures, their dispositions in the
bilayers, and the response of the bilayers to the peptides.
Our results demonstrate that the translocating peptide has
the ability to penetrate deep into the bilayer without causing
significant bilayer perturbations.MATERIALS AND METHODS
Reagents and peptides
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and DPPE-
PEG2K (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-n-[methoxy
(polyethylene glycol)-2000]) were purchased from Avanti Polar Lipids
(Alabaster, AL). The sequences of the peptides investigated here, TP2 and
ONEG, are shown in Fig. 1. The peptides were synthesized and purified by
Bio-Synthesis, Inc. (Lewisville, TX). For the neutron diffraction experi-
ments, peptides were synthesized with deuterated leucines and glycines as
indicated in Fig. 1. The deuterated amino acids were from C/D/N Isotopes
(Pointe Claire, Que´bec, Canada).Binding measurements
The mole fraction partition coefficients describing peptide binding to POPC
large unilamellar vesicles (LUVs) were measured using equilibrium dial-
ysis (9). In this assay, a semipermeable membrane separates two compart-
ments, with LUVs added to only one of them. The peptide is added to either
compartment and allowed to equilibrate such that the aqueous concentra-
tion of the free peptide becomes the same in the two compartments. In addi-
tion to free peptide, the compartment with the LUVs also contains the
bound peptide. Because the semipermeable membrane allows passage
and equilibration of peptides but not vesicles, measurements of the total
peptide concentration in the two chambers yield the free, [P]w, and the
freeþbound, [P]w þ [P]b, peptide concentrations. These peptide concentra-
tions were determined using HPLC as described previously by Wimley and
co-workers (10–12). Mole fraction partition coefficients were calculated as
KX ¼ ½Pb=ð½LÞ½Pw=ð½WÞ
; (1)
where [L] and [W] are the molar concentrations of lipid and water.TP2 PLIYLRLLRGQF
TP2-D PLIYLRLLRGQF
ONEG PLGRPQLRRGQF
ONEG-D PLGRPQLRRGQF
FIGURE 1 Amino-acid sequences of the translocating peptide TP2 and
the inactive control ONEG. The amino acids that were deuterated for the
neutron diffraction experiments are shown in bold and underlined.
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ence of 10, 50, and 100 mM POPC. The partition coefficients can be used to
calculate the fraction of peptide bound (fb), at any lipid concentration [L],
using the following equation:
fb ¼ Kx½L
Kx½L þ ½W: (2)
Circular dichroism
Circular dichroism (CD) is a technique that reports on the secondary struc-
ture of proteins (13–16). The CD spectra were collected using a model No.
810 spectropolarimeter (JASCO, Easton, MD). Samples were placed in a
1-mm path-length quartz cuvette at room temperature. At least three spectra
were collected at a scan rate of 10 nm/min, and averaged. After subtraction
of background, the mean residue ellipticity was calculated using the peptide
concentration.Oriented CD
Oriented CD (OCD) can provide information about the secondary structure
of peptides embedded into multibilayer samples (17–20). Multilayer sam-
ples containing 5 mol % peptides were prepared by dissolving the peptides
in methanol and POPC in chloroform (21,22). The two solutions were
mixed in the appropriate ratios, and a multibilayer sample was prepared
by applying the solution dropwise on a quartz slide. After solvent evapora-
tion, the slide was placed perpendicular to the beam in a custom-designed
chamber as described previously (18,19,23–25). To hydrate at 76% relative
humidity (RH), a drop of saturated NaCl solution was placed in the chamber
and the sample was equilibrated (25,26). Eight spectra were recorded while
rotating the sample holder around the beam axis in increments of 45. These
spectra were averaged and then corrected for lipid background as described
by Hristova and co-workers (25,26).Neutron diffraction experiments: data collection
and analysis
Neutron diffraction is a useful technique that yields information about the
structure of lipid bilayers and the disposition of membrane-bound peptides
(27–34). The neutron diffraction experiments were performed at the
Advanced Neutron Diffractometer/Reflectometer at the National Institute
of Standards and Technology Center for Neutron Research, Gaithersburg,
MD (35).
The samples were prepared similarly to the samples used in the OCD ex-
periments. The samples consisted of lipid bilayer stacks aligned along the
surface of a solid support. The oriented multilayer samples, ~5-mm thick,
were prepared as dry lipid films spread over an area of ~1.5  1.5 cm2 on
thin glass slides, and hydrated from the vapor phase of a saturated salt solu-
tion. A relative humidity of 76%wasmaintained throughout the experiments
by using containers with saturatedNaCl solution placed next to the sample in
a sealed aluminum chamber. Diffraction data were collected by rotating the
average lipid bilayer plane through the angleQ, and detecting the diffracted
beam at angle 2Q, relative to the beam direction. This configuration was
chosen to ensure that the momentum transfer between the incident and dif-
fracted neutron wave vectors was always perpendicular to the multilayer
plane, thus probing the density distribution along the bilayer normal. Several
(Q–2Q) scans were collected, monitoring changes in the diffraction pattern
as the sample equilibrated. Only data collected after full sample equilibra-
tion were used for determining the bilayer density profile.
The sample was exposed to a neutron beam of wavelength 5 A˚, and the
intensity of the diffracted beam was recorded using a He-3 gas-filled 25.4-
mm-wide pencil detector (GE/Reuter-Stokes, Twinsburg, OH) (36–38).
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REFLRED, developed at the National Institute of Standards and Technol-
ogy Center for Neutron Research. Data analysis was performed with the
commercially available software package ORIGIN (OriginLab, Northamp-
ton, MA). The observed structure factors were calculated as
f ðhÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
IðhÞ sinð2QÞ
p
; (3)
where I(h) is the intensity of the hth peak, and Q is the Bragg angle.
The peaks were integrated in the software ORIGIN using two different
methods: numerical integration of the areas under the peaks (IA), or by
fitting Gaussians to the diffraction peaks and integrating analytically (IG).
The average of the two areas given by the two methods yielded I(h) as
used in Eq. 1. The experimental uncertainties in the peak intensities were
calculated as the square-root of the intensities (neutron counts). The dif-
ference between IG and IA was similar to the uncertainties calculated in
this way.Absolute scaling
The absolute scattering length density r*(z) is the scattering density per
lipid molecule, given by (39)
rðzÞ ¼ rðzÞS ¼ r0 þ
2
d
,
1
k
Xhobs
h¼ 1
f ðhÞ cos

2phz
d

; (4)
where f(h) values are the measured structure factors on an arbitrary scale; k
is the instrumental constant; d is the Bragg spacing; r0* is the average scat-
tering length density of the unit cell; and hobs is the highest observed
diffraction order. FðhÞ ¼ f ðhÞ=k are the absolute structure factors, which
are determined solely by the structure and the scattering of the unit cell
(26,40).
The instrumental constant k and the absolute structure factors
FðhÞ ¼ f ðhÞ=k can be determined if diffraction patterns are recorded for
two samples with isomorphous unit cells, i.e., identical except for a few
atoms with large differences in scattering lengths (26,40,41). Here we
compared structure factors for POPC bilayers containing hydrogenated
and deuterated peptides (sequences shown in Fig. 1), as discussed below.
Five mol % deuterated TP2 and ONEG introduced 2.47 and 1.52 deuterons
per lipid, respectively, providing sufficient contrast to scale the structure
factors.
The absolute structure factors F(h) were obtained from the experimen-
tally determined structure factors f(h) by calculating the instrumental con-
stants k(h), as well as the width and the position of the deuterated amino
acids within the thickness of the bilayer, AD and ZD, according to
f TP2-D
kTP2-D
 f
TP2
kTP2
¼ 2bTP2D exp
 pATP2D h=d2
cos2phZTP2D =d; h ¼ 1;.; hobs;
(5)
f ONEG-D f ONEG   2
kONEG-D

kONEG
¼ 2bONEGD exp  pAONEGD h=d
cos2phZONEGD =d; h ¼ 1;.; hobs:
(6)
Here bD is the neutron scattering length difference due to the hydrogen/
deuterium substitution in the peptides (scattering length for hydrogen is
0.3739 1012 cm and for deuterium is 0.6671 1012 cm). Four orders
of diffraction were recorded in all experiments, i.e., hobs¼ 4. The system of
four expressions in Eq. 5 was used to calculate the four unknown parame-
ters for TP2:kTP2-D; kTP2; ATP2D ; and Z
TP2
D :
The set of expressions in Eq. 6 was used to determine the four unknown pa-
rameters for ONEG:
kONEG-D; kONEG; AONEGD ; and Z
ONEG
D :
The absolute structure factors were calculated using the following
equations:
FTP2 ¼ f
TP2
kTP2
;
FTP2-D ¼ f
TP2-D
kTP2-D
;
FONEG ¼ f
ONEG
kONEG
; and
FONEG-D ¼ f
ONEG-D
kONEG-D
:
(7)
Leakage of ANTS and DPX from POPC vesicles
We measured the peptide-induced leakage of the fluorophore/quencher pair
ANTS/DPX from POPC vesicles as described in Ellens et al. (42) and Hris-
tova et al. (43,44). Unilamellar vesicles of 0.1-mm diameter were made by
extrusion of multilamellar vesicles through a polycarbonate filter with
0.1-mm diameter pores (Nucleopore; Millipore, Billerica, MA) (42–44).
Unencapsulated ANTS and DPX were removed with gel filtration. In
leakage experiments, ANTS fluorescence of 1 mM solution of ANTS/
DPX-containing vesicles was measured as a function of time, before and
after the addition of peptides at different concentration. The fluorescence
for 100% leakage was determined by the addition of 0.4 vol % (v/v) of
the detergent Triton X-100, which causes vesicle solubilization. Fluores-
cence was measured with a Fluorolog spectrophotometer from Horiba Jobin
Yvon (Edison, NJ) using excitation and emission wavelengths of 355 nm
(slit 2.5 nm) and 520 nm (slit 2.5 nm), respectively. The contribution of
light scattering was negligible under these conditions.Supported bilayers and electrochemical
impedance spectroscopy
Previously we have characterized the response of asymmetric, diphytanoyl
PC-containing bilayers to TP2 and ONEG (45). To make a direct compar-
ison using a variety of techniques for POPC bilayers, we performed a new
set of electrochemical impedance spectroscopy (EIS) experiments in
POPC. As described in detail in Lin et al. (46), we prepared polymer-cush-
ioned, surface-supported POPC bilayers on silicon by Langmuir-Blodgett
deposition of monolayers composed of POPC and 5.9 mol % DPPE-
PEG2K, followed by fusion of 0.1-mm unilamellar POPC vesicles. The sup-
port was highly doped n-silicon (47), cleaned with consecutive washes of
IPA, acetone, IPA, and a Piranha etch solution (34% hydrogen peroxide,
66% sulfuric acid). A 1 mg/mL chloroform solution of POPC with
5.9 mol % DPPE-PEG2K was deposited onto the surface of a Langmuir-
Blodgett trough (KSV NIMA, Biolin Scientific, Linthicum Heights, MD).
After solvent evaporation, the monolayer was compressed to 32 mN/m.
Deposition of the POPC/DPPE-PEG2K monolayer on the silicon wafer
was accomplished by withdrawing the silicon from the buffer through the
monolayer at a speed of 15 mm/s, while maintaining constant surface pres-
sure. Next, a Teflon electrochemical cell was sealed to the surface of the sil-
icon and 450 mL of a 1.3-mM solution of POPC unilamellar vesicles wasBiophysical Journal 104(11) 2419–2428
2422 Cruz et al.added to the cell. Incubation for 1 h allowed for a surface-supported bilayer
to form by vesicle fusion. After that, 10 mL phosphate buffer containing
100 mM KCl was added to the cell, bringing the vesicle concentration to
60 mM and the bilayer was allowed to equilibrate for 24 h before
measurements.
An Ag/AgCl reference electrode and a Pt counter electrode were placed
in contact with the buffer solution, and a ground connection was made to the
silicon (46). The impedance spectra were measured across the frequency
range from 105 to 1 Hz with a DC bias voltage of zero. In each experiment,
the impedance of the bilayer was first measured, and then the peptide was
added to the vesicle solution in the chamber (48,49) such that the overall
peptide/lipid was defined. After peptide addition, the impedance response
was measured every 2 min continuously for 1 h. The impedance response
was analyzed by fitting the measured response to an ideal RC circuit as
described in Lin et al. (47).RESULTS
Binding of TP2 and ONEG to POPC bilayers
We measured the mole fraction partition coefficients for
TP2 and ONEG, using equilibrium dialysis as described in
Materials and Methods and White et al. (9). Briefly, we
used HPLC to measure the concentrations of free and bound
peptides at equilibrium in the presence of POPC vesicles at
lipid concentrations of 10, 50, and 100 mM (the range over
which binding was experimentally measurable). The calcu-
lated mole fraction partition coefficients are shown in Table
1. The averages of all experiments are KTP2 ¼ 32005 800
and KONEG ¼ 190 5 10. Importantly, the partition coeffi-
cients were independent of the lipid concentration over
the measurable range. This finding suggests that binding is
not influenced by peptide self-association in the membrane,
as has been observed for other families of peptides (50).
Thus, the peptides likely partition into the bilayer as mono-
mers. The measured partition coefficients can therefore be
converted to fraction of peptide bound for any lipid concen-
trations, such as in the CD experiments described below, us-
ing Eq. 2.
The weak, but measurable binding of TP2 is consistent
with its observed membrane translocation. We previously
estimated the rate of translocation of TP2-TAMRA across
a bilayer to be between 0.1 and 1 s1 by assuming that
10% of the peptide was bound (8). Based on the data pre-
sented here, we calculate that ~5% of TP2 is bound at
1 mM POPC so the previous estimate of translocation rate
must be close to the true value. In the presence of cells orTABLE 1 Binding of TP2 and ONEG to POPC large unilamellar
vesicles measured by equilibrium dialysis
Lipid (mM)
TP2 ONEG
Partition coefficient
10 36005 500 1805 6
50 23005 500 2105 6
100 39005 500 2005 6
Average 32005 800 1905 10
The uncertainties are standard errors.
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population of bound peptide. This bound peptide, coupled
with an inherently high rate of translocation, is sufficient
to explain the observed behavior of TP2.Peptide secondary structure
The CD spectra of the two peptides in phosphate buffer
at pH 7 are shown in Fig. 2. ONEG is unstructured in buffer,
as evident from the minimum at 200 nm which is indicative
of a random coil. TP2 is also mostly random coil in buffer,
but the shallow minimum at 210–220 nm suggests that
there may be a small amount of unidentifiable secondary
structure.
Fig. 2 also shows the CD spectra in the presence of 5 mM
LUVs. There is no change in the signal for ONEG, with the
minimum remaining at ~200 nm. However, from the binding
measurements, we calculate that only ~2% of the peptide is
bound to the vesicles at this lipid concentration, and thus the
contribution of bound ONEG to the CD spectrum is small
and we cannot conclude whether or not ONEG is structured
in membranes from this experiment. The TP2 spectrum
changes slightly in the presence of vesicles. In this case,
~20% of TP2 is bound to the vesicles. However, the change
in the CD signal is small, and thus the exact secondary struc-
ture of bound TP2 cannot be determined from the spectra.
We can conclude, however, that:
1. TP2 is more structured than ONEG both in the absence
and presence of vesicles; and
2. The degree of TP2 secondary structure increases upon
binding to membranes.
To better assess the differences in secondary structure
propensity between TP2 and ONEG when they are associ-
ated with bilayers, we used oriented circular dichroism
(OCD). In an OCD experiment, samples consist of oriented
multibilayer stacks containing peptides (18–20). These sam-
ples are produced by aliquoting peptides and lipids, codis-
solved in methanol, onto a quartz disk, followed byFIGURE 2 CD spectra of 100 mM TP2 and ONEG in buffer and in the
presence of 5 mM POPC liposomes. In both samples, TP2 has more second-
ary structure.
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through the vapor phase. Although the oriented bilayers
are in the fluid phase, there is no bulk aqueous phase for
the peptides to explore. Therefore, all peptides are associ-
ated with the bilayer, at least interfacially. The concentration
of both TP2 and ONEG in the bilayers are 5 mol %, as ali-
quoted. The OCD spectra are shown are Fig. 3, and they are
distinctly different for the two peptides. The minimum at
200 nm observed for ONEG is indicative of a random
coil, although the very low intensity may suggest the pres-
ence of some small amount of secondary structure. The
OCD signal of TP2, on the other hand, shows a distinct
single minimum at ~215 nm indicative of an extended or
b-sheet-like structure. We therefore conclude that the trans-
locating peptide TP2 has a significantly higher propensity
for secondary structure than the nontranslocating peptide
ONEG. As the binding experiments suggest that no signifi-
cant TP2 oligomerization occurs in the membrane, the struc-
ture of membrane-bound TP2 is not likely a b-sheet
oligomer.Peptide disposition in bilayers
We used neutron diffraction to assess the disposition of the
two peptides in POPC bilayers. Samples for the neutron
diffraction experiments, like the OCD samples, were
stacked multilayer samples containing TP2 and ONEG, or
their deuterated versions TP2-D and ONEG-D. The deuter-
ated amino acids in TP2-D and ONEG-D are shown in bold
in Fig. 1. The multilamellar samples were placed in the
neutron beam and equilibrated at 76% RH. The thermal dis-
order in the structure is lower at 76% RH than at full hydra-
tion, which allowed us to observe four orders of diffraction
in all experiments (a requirement for subsequent data anal-
ysis (26)). Just like in the OCD experiments, there is no bulk
aqueous phase for the peptides to explore and the peptide
concentration is 5 mol % in all cases.
The goal of these experiments was to measure the trans-
bilayer distribution of the deuterium labels in bilayers con-FIGURE 3 OCD spectra of 5 mol % TP2 and ONEG in oriented multi-
bilayers of POPC, equilibrated at 76% relative humidity in a sealed cham-
ber through the vapor phase.taining either TP2 or ONEG. To compare the neutron
scattering length density profiles of different samples, the
profiles were scaled and placed on the so-called absolute
scale using the scaling protocol given in Materials and
Methods and elsewhere (26,37,38,40,41). The absolute
structure factors for POPC bilayers with 5 mol % TP2,
TP2-D, ONEG, and ONEG-D, together with the measured
Bragg spacings, are shown in Table 2. In Table 3 we show
the center and the 1/e half-width of the Gaussians that
describe the deuterium distribution across the bilayers.
Whereas the widths of the two deuterium distributions,
AONEGD and A
TP2
D , are similar, the centers of the deuterium
distributions, ZONEGD and Z
TP2
D , are different. In particular,
the center of the TP2 deuterium distribution is closer
to the bilayer center, indicating that TP2 resides deeper in
the POPC bilayer, as compared to ONEG.
The direct comparison of the absolute profiles in Fig. 4
reveal the position of the deuterated amino acids within
the bilayer thickness. The top panel in Fig. 4 compares the
profiles of POPC bilayers with 5 mol % TP2 (solid line)
and 5 mol % TP2-D (dashed line), hydrated at 76% RH.
The difference between the profiles for TP2 and TP2-D is
due to the replacement of hydrogens with deuterons in the
leucines in TP2 (Fig. 1). The bottom panel compares the
profiles for ONEG and ONEG-D. The deuterium label pro-
file for TP2, obtained by subtracting the POPC/TP2 profile
from the POPC/TP2-D profile, is shown in Fig. 5 (top) and
the difference profile for POPC/ONEG is shown in Fig. 5
(bottom). The difference profiles show that the TP2 deute-
rium distribution goes to zero at the edge of the unit cell.
In the case of ONEG, however, there is significant electron
density due to the peptide at the edge of the unit cell,
because of the overlap of peptide distributions from the
neighboring unit cells. This finding is consistent with the
fact that the center of the deuterium Gaussian distribution
for TP2 is closer to the bilayer center. As the deuterated
amino acids are distributed throughout the peptide
sequence, these results suggest that TP2 penetrates deeper
into the bilayer, as compared to ONEG. Thus, the incorpo-
ration of ONEG into the bilayers is more superficial.
The Bragg spacing measured in diffraction experiments
is very sensitive to peptide-induced changes in bilayerTABLE 2 Absolute structure factors and their experimental
uncertainties for POPC multilayers with 5 mol % peptide
ha TP2 TP2-D ONEG ONEG-D
1 7.905 0.1c 8.825 0.1 2.445 0.02 3.785 0.02
2 3.765 0.2 6.205 0.2 1.285 0.03 1.945 0.03
3 4.685 0.3 5.705 0.3 1.345 0.03 1.965 0.04
4 3.805 0.2 3.605 0.3 0.535 0.03 0.645 0.04
d (A˚)b 51.35 0.5 51.35 0.5 47.45 0.3 47.45 0.3
aDiffraction order.
bBragg spacing. For comparison, the Bragg spacing of neat POPC bilayers
at 76% RH is 52.45 0.3 A˚.
cUncertainties in the structure factors are standard deviations calculated
using the square-root of the number of raw counts collected.
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TABLE 3 Gaussian parameters for the TP2 and ONEG
deuterium distributions in POPC bilayers containing 5 mol %
TP2 or ONEG
TP2 ONEG
ZD (A˚)
a 14.85 0.3c 16.075 0.01
AD (A˚)
b 6.2 5 0.1 6.295 0.02
aCenter of the deuterium distribution.
bWidth of the deuterium distribution.
cUncertainties in fit parameters are standard deviations calculated by
numerical propagation of the errors in the structure factors.
FIGURE 5 Difference neutron scattering profiles, showing the transbi-
layer distribution of the deuterated amino acids in TP2 (top) and ONEG
(bottom).
2424 Cruz et al.structure. While the Bragg spacing for pure POPC bilayers
at 76% RH was 52.45 0.3 A˚, the incorporation of ONEG
into bilayers decreases the bilayer spacing to 47.45 0.3 A˚,
indicative of a significant bilayer thinning (Table 2). Bilayer
thinning suggests that the area per lipid molecule increases
in the presence of ONEG, likely due to increased trans-
gauche isomerization of the acyl chains, i.e., due to
increased thermal disorder in the bilayer. Despite its deeper
penetration into the membrane, 5 mol % TP2 has only a very
small effect on the bilayer structure, decreasing the Bragg
spacing by 1.1 5 0.6 A˚ to 51.3 5 0.5 A˚, a change that is
not much larger that the experimental uncertainty in the
measurement. Therefore, the TP2 sequence is very well
tolerated by the lipids and does not cause large bilayer per-
turbations even at the high concentration of 5 mol %.FIGURE 4 Absolute neutron scattering length density profiles for bila-
yers with (top) 5 mol % TP2 (solid line) and TP2-D (dashed line), as well
as (bottom) 5 mol % ONEG (solid line) and ONEG-D (dashed line). The
profiles are created using the absolute structure factors shown in Table 2.
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Next, we investigated the effect of TP2 and ONEG on the
integrity of POPC bilayers by measuring bilayer permeabi-
lization using the ANTS/DPX vesicle leakage assay. In this
assay, the ANTS fluorescence is quenched inside the vesi-
cles due to the presence of DPX, but increases when the
encapsulated contents leak out due to ANTS/DPX dilution.
The addition of the detergent Triton-X 100, which solubi-
lizes the vesicles, is used to measure the fluorescence for
100% leakage. In Fig. 6, we show that the increase in
ANTS fluorescence caused by the addition of TP2 is very
small. Although only 5% of TP2 is bound in this experi-
ment, these are the conditions under which translocation
takes place (8), and we would expect to see membrane
destabilization if it occurs. When the aqueous TP2 concen-
tration is 20 mM, the ratio of bound peptide/lipid is ~1:1000,
a ratio for which many membrane-active peptides cause
substantial membrane leakage (24,25,51,52). Similarly to
TP2, ONEG causes no leakage from POPC vesicles, but
this result is trivial because the bound fraction is only
0.3% under these conditions.
The effect of TP2 on the integrity of surface-supported
POPC bilayers was probed using electrochemical imped-
ance spectroscopy (EIS). EIS yields direct measurements
of bilayer resistance and capacitance as a function of time
(47). This technique is highly sensitive to subtle defects in
bilayer structure that may not be observable in vesicle
leakage experiments (45). Supported POPC bilayers on
PEG cushions were prepared as described in Materials and
Methods. The resistance and the capacitance were obtained
FIGURE 6 Leakage of the dye ANTS and the quencher DPX from
vesicles in response to TP2 and ONEG. Lipid concentration is 1 mM total.
Peptide concentrations are 2, 10, and 20 mM.
FIGURE 7 Normalized resistance and capacitance of polymer cush-
ioned, surface-supported POPC bilayers after the addition of TP2. The pep-
tide concentration was 100 mM, the lipid concentration was 60 mM, and the
bound peptide/lipid was ~1:200.
Membrane-Translocating Peptides 2425by fitting the impedance spectra to an ideal parallel RC cir-
cuit as described in detail in the literature (45–47,49). The
initial membrane resistance (Rm) values were 1.24  104
5 4.6 103U cm2. While higher values have been reported
(53), this value is very similar to resistances measured for
lipid bilayers formed on the tips of patch pipettes (54).
The initial capacitance value was 0.745 0.08 mF/cm2, cor-
responding to a bilayer thickness of 4.85 0.8 nm, assuming
a relative permittivity of 4.
Fig. 7 shows the normalized resistance (top) and capaci-
tance (bottom) after the addition of TP2 to a final concentra-
tion of 100 mM, corresponding to 1:200 bound peptide/
lipid. TP2 does not affect either the resistance or the capac-
itance of the bilayer at this high concentration. No effects
were observed at lower concentrations, either (results not
shown).
We recently published an EIS study of the membrane-per-
meabilizing peptides melittin and alamethicin using exactly
the same methodology and supported bilayers as used in this
work (55). The EIS response of the bilayers is extremely
sensitive to these pore-forming peptides at bound concentra-
tions that are much lower than the concentration of TP2 used
here. For example, alamethicin causes an exponential
decrease in the equilibrium bilayer resistance of ~50%, at
the very low bound peptide/lipid of 1:2000. The equilibrium
resistance decreases by >90% when this ratio is 1:200 (55).
The EIS results in Fig. 7 thus demonstrate that the translo-
cating peptide is causing essentially no disruption of thebilayer at bound concentrations for which alamethicin de-
stroys the bilayer. ONEG binding to bilayers is much lower,
such that a direct comparison of the effect of TP2, ONEG,
and alamethicin at identical bound concentrations is not
feasible.DISCUSSION
The permeability barrier of the lipid bilayer to polar com-
pounds is due to the hydrophobic nature of the membrane,
especially the hydrocarbon core. A small hydrophobic
molecule, such as a drug, will likely translocate across a
lipid bilayer membrane without disrupting it (56). This oc-
curs by simple stepwise partitioning from water into the
bilayer interface, and then from the interface across the hy-
drocarbon core, which proceeds without any insurmount-
able energy barriers. A very different mechanism of
membrane translocation is used by highly amphipathic mol-
ecules such as detergents or pore-forming peptides (57,58).
They cross bilayers by disrupting bilayer integrity via
various mechanisms, and their translocation is a conse-
quence of bilayer permeabilization.
Both of the peptides studied here were selected in a screen
that specifically assayed for lack of bilayer permeabiliza-
tion. ONEG was selected for lack of permeabilization in
a high-throughput Tb3þ/dipicolinic acid assay (8) and for
lack of translocation at a peptide/lipid of 1:200. TP2
was selected for lack of permeabilization and for rapidBiophysical Journal 104(11) 2419–2428
2426 Cruz et al.translocation. To further validate this functional selection,
here we used two different methods to assess the peptide-
induced membrane permeabilization at various peptide con-
centrations, including higher concentrations than the ones
used in the high-throughput screen. While the screen was
conducted in POPC vesicles containing 10% anionic
POPG, the selected peptides were shown to translocate
just as efficiently through bilayers made of 100% POPC
(8). Therefore, anionic lipids are not required for transloca-
tion. In this work, all experiments were conducted with
100% POPC.
First, we used a vesicle-based assay to show that neither
peptide causes leakage of the fluorescent probe ANTS or
its quencher DPX in experiments conducted at total pep-
tide/lipid up to 1:50 (Fig. 6).
Second, we used impedance spectroscopy, which is much
more sensitive to bilayer disruption than the vesicle leakage
assays, and we showed that TP2 does not increase the
permeability of the surface-supported POPC bilayers at
very high concentrations (1 bound peptide per 200 lipids
(Fig. 7)).
To further investigate the behavior of the two peptides in
bilayers, we assayed membrane binding, peptide secondary
structure, peptide disposition in the bilayer, and effects on
bilayer structure. We observed modest but obvious differ-
ences in the behavior of the two peptides. The translocating
peptide TP2, as compared to ONEG:
1. Binds somewhat better as shown by equilibrium dialysis;
2. Is more prone to secondary structure, shown by circular
dichroism;
3. Penetrates deeper into bilayers, as evidenced from the
position of the Gaussian distribution of the peptides
from neutron diffraction; and
4. Is less perturbing to the bilayer structure, as suggested by
the smaller decrease in Bragg spacing in diffraction ex-
periments.
Perhaps the most revealing result of these studies is the
deeper bilayer insertion of the translocating peptide TP2,
in combination with its very small effect on bilayer struc-
ture, even at high TP2 bilayer concentrations (5 mol %).
At this concentration, TP2 decreased the Bragg spacing by
~1 A˚, while the same amount of the negative peptide
ONEG decreased the Bragg spacing of the bilayer by
~5 A˚. Similar bilayer thinning effects have been observed
for other membrane-active peptides (24,25,51,52). The thin-
ning effect is attributed to the peptide inserting between
lipids at the interface and increasing chain disorder via
increased trans-gauche isomerization (24). The small effect
of TP2 on bilayer structure suggests that the packing of the
lipids is not much affected by peptide insertion, despite the
fact that TP2 inserts deeper into the membrane than ONEG.
How can a polycationic peptide like TP2 translocate
across bilayers? TP2 would not be predicted to cross bila-
yers by spontaneous passive diffusion based on octanolBiophysical Journal 104(11) 2419–2428partition coefficients, i.e., hydropathy (10) or LogP values
(56), because the multiple arginine residues make it much
too polar (59). At the same time, it does not cross bilayers
using the mechanism of other amphipathic peptides that
translocate as a result of bilayer permeabilization. This un-
usual behavior could be due to the conserved LRLLR motif
contained within TP2 and within most of the other translo-
cating peptide sequences that were selected in the screen
(8). Very similar highly conserved motifs are also found,
concatenated together three times, in the S4 voltage sensor
helices of voltage-gated potassium channels (60). In ion
channel gating, the S4 segment with its four arginines has
been proposed to move freely across the bilayer in response
to membrane voltage (61). We have shown experimentally
that isolated S4 helices, with four arginine residues, translo-
cate spontaneously across synthetic bilayers (62).
The available evidence in this and previous work suggests
that TP2 partitions into and translocates across the mem-
brane as a monomer. For example, the binding experiments
reported here for TP2 show no dependence of the partition
coefficient on peptide concentrations (Table 1). Previously
reported translocation experiments in Marks et al. (8) and
recent unpublished data demonstrate that the rate of translo-
cation does not depend on the peptide concentration and on
the peptide/lipid, for ratios from 0.00017 (1:6000) to 0.005
(1:200). The lack of concentration dependence of the trans-
location rate is consistent with the idea that TP2 translocates
as a monomer. The isolated S4 helix also translocates at very
low peptide/lipid (0.00017), similar to TP2, suggesting that
it also translocates as a monomer in synthetic systems, just
as it moves across the bilayer as a monomer within the
context of the full-length potassium channel.
The LRLLR motif has the same general amino-acid
composition as most membrane-destabilizing peptides
such as melittin or the antimicrobial peptides, which are
rich in cationic and hydrophobic amino acids. Such mem-
brane-destabilizing peptides have ‘‘imperfect amphipathic-
ity’’ (57) in which nonpolar surfaces are interrupted by
polar and/or charged residues. When an imperfectly amphi-
pathic, membrane-active peptide partitions into a bilayer,
the nonpolar residues are thought to force the insertion of
polar residues, thereby disrupting the bilayer structure and
allowing the flow of polar solutes across the membrane.
As the bilayer is remarkably unperturbed by TP2, the
LRLLR motif obviously does not behave like the imper-
fectly amphipathic antimicrobial peptides even at high con-
centration. Instead, we speculate that the LRLLR motif is an
ideal lipid interaction motif, with the arginine residues in
relative positions and separation that allows them to interact
with lipid phosphate groups without disrupting the bilayer.
When chaperoned by lipid phosphates, the entire complex
of peptide and lipid can translocate across the bilayer spon-
taneously without bilayer disruption. This idea not only ex-
plains the selection of the LRLLR motif in the high
throughput screen for translocating peptides but also
Membrane-Translocating Peptides 2427provides a testable hypothesis for the next stage of this
work. In particular, it will be interesting to create sequence
variants, and then seek correlations among translocation,
bilayer disruption, and Bragg spacing from neutron diffrac-
tion experiments for these sequence variants.
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